Q-pam
Drug - Q-pam
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Diazepam
Multiple ingredients are in alphabetical order.
Strength -
10MG
The potency of the active ingredient(s), Diazepam. May repeat for multiple part products.
Applicant -
QUANTUM PHARMICS
The firm name holding legal responsibility for Q-pam. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
070425
The FDA assigned number to Q-pam. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Q-pam. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Dec 12, 1985
The date Q-pam was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Q-pam. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Q-pam is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Quantum Pharmics Ltd
The full name of the firm holding legal responsibility for the new application of Q-pam.
Q-pam
|